CAM
WST icon

Capstone Asset Management’s West Pharmaceutical WST Stock Holding History

Capstone Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$919K Sell
9,720
-440
-4% -$40.5K 0.03% 617
2017
Q1 		$829K Buy
10,160
+234
+2% +$19.6K 0.02% 653
2016
Q4 		$842K Sell
9,926
-980
-9% -$77.1K 0.02% 642
2016
Q3 		$812K Buy
10,906
+490
+5% +$38.9K 0.02% 673
2016
Q2 		$790K Buy
10,416
+4,020
+63% +$293K 0.02% 676
2016
Q1 		$443K Buy
6,396
+250
+4% +$15K 0.01% 999
2015
Q4 		$370K Sell
6,146
-70
-1% -$4.21K 0.01% 1123
2015
Q3 		$336K Sell
6,216
-15,890
-72% -$926K 0.01% 1158
2015
Q2 		$1.28M Sell
22,106
-11,910
-35% -$665K 0.04% 509
2015
Q1 		$2.05M Buy
34,016
+760
+2% +$40.5K 0.06% 380
2014
Q4 		$1.77M Sell
33,256
-7,890
-19% -$395K 0.05% 413
2014
Q3 		$1.84M Buy
41,146
+270
+0.7% +$11.5K 0.06% 352
2014
Q2 		$1.72M Buy
40,876
+4,380
+12% +$188K 0.06% 393
2014
Q1 		$1.61M Sell
36,496
-197
-0.5% -$9.27K 0.05% 419
2013
Q4 		$1.8M Sell
36,693
-567
-2% -$26.5K 0.05% 406
2013
Q3 		$1.53M Buy
37,260
+1,420
+4% +$54.2K 0.04% 558
2013
Q2 		$1.26M Buy
+35,840
New +$1.18M 0.03% 603

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Capstone Asset Management's WST Position: Q2 2017 in Review

Capstone Asset Management reduced its West Pharmaceutical (WST) stake by 4.3% in Q2 2017, selling an estimated $40.5K and leaving 9,720 shares worth $919K. The position accounts for 0.03% of the portfolio, ranked #617.

Capstone Asset Management first reported a position in WST in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.05M in Q1 2015. 309 funds tracked by Wall St. Rank hold WST as of Q2 2017.

  • Capstone Asset Management held 9,720 shares of West Pharmaceutical worth $919K as of Q2 2017.
  • Capstone Asset Management sold 440 West Pharmaceutical shares in Q2 2017, an estimated $40.5K.
  • West Pharmaceutical made up 0.03% of Capstone Asset Management's portfolio in Q2 2017, its #617 holding.
  • Capstone Asset Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's West Pharmaceutical position peaked at $2.05M in Q1 2015.
  • 309 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.